CHAMPIONS ONCOLOGY, INC. Cash and Cash Equivalents, Period Increase (Decrease)
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$2.44 million for the 12-month period ending 2018-04-30, per its 10-K filed 2018-07-30.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-07-30
- CHAMPIONS ONCOLOGY, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-04-30 was -$206.00K.
- CHAMPIONS ONCOLOGY, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-01-31 was $402.00K.
- CHAMPIONS ONCOLOGY, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-10-31 was $230.00K.
- CHAMPIONS ONCOLOGY, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-07-31 was -$2.87M, a 252.56% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$2.44M, a 443.52% decline from fiscal 2017.
- CHAMPIONS ONCOLOGY, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $710.00K.
- CHAMPIONS ONCOLOGY, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$6.77M, a 295.38% decline from fiscal 2015.
- CHAMPIONS ONCOLOGY, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $3.47M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-04-30 | -$206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $196.00K derived: sum of 2 quarters · filed 2018-07-30 | $426.00K derived: sum of 3 quarters · filed 2018-07-30 | -$2.44M 10-K · filed 2018-07-30 |
| 2018-01-31 | $402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $632.00K derived: sum of 2 quarters · filed 2018-03-19 | -$2.23M 10-Q · filed 2018-03-19 | -$2.43M derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-10-31 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | -$2.63M 10-Q · filed 2017-12-15 | -$2.83M derived: sum of 3 quarters · filed 2018-07-30 | -$3.67M derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-07-31 | -$2.87M 10-Q · filed 2017-09-14 | -$3.06M derived: sum of 2 quarters · filed 2018-07-30 | -$3.90M derived: sum of 3 quarters · filed 2018-07-30 | -$4.03M derived: sum of 4 quarters · filed 2018-07-30 |
| 2017-04-30 | -$193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | -$1.03M derived: sum of 2 quarters · filed 2018-07-30 | -$1.17M derived: sum of 3 quarters · filed 2018-07-30 | $710.00K 10-K · filed 2018-07-30 |
| 2017-01-31 | -$840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | -$975.00K derived: sum of 2 quarters · filed 2018-03-19 | $903.00K 10-Q · filed 2018-03-19 | $195.00K derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $1.74M 10-Q · filed 2017-12-15 | $1.03M derived: sum of 3 quarters · filed 2017-12-15 | $171.00K derived: sum of 4 quarters · filed 2017-12-15 |
| 2016-07-31 | $1.88M 10-Q · filed 2017-09-14 | $1.17M derived: sum of 2 quarters · filed 2017-09-14 | $306.00K derived: sum of 3 quarters · filed 2017-09-14 | -$2.30M derived: sum of 4 quarters · filed 2017-09-14 |
| 2016-04-30 | -$708.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | -$1.57M derived: sum of 2 quarters · filed 2017-07-28 | -$4.17M derived: sum of 3 quarters · filed 2017-07-28 | -$6.77M 10-K · filed 2017-07-28 |
| 2016-01-31 | -$864.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | -$3.47M derived: sum of 2 quarters · filed 2017-03-17 | -$6.06M 10-Q · filed 2017-03-17 | $3.11M derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-10-31 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | -$5.20M 10-Q · filed 2016-12-14 | $3.98M derived: sum of 3 quarters · filed 2016-12-14 | $3.58M derived: sum of 4 quarters · filed 2016-12-14 |
| 2015-07-31 | -$2.60M 10-Q · filed 2016-09-14 | $6.58M derived: sum of 2 quarters · filed 2016-09-14 | $6.18M derived: sum of 3 quarters · filed 2016-09-14 | $3.71M derived: sum of 4 quarters · filed 2016-09-14 |
| 2015-04-30 | $9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $8.78M derived: sum of 2 quarters · filed 2016-07-29 | $6.30M derived: sum of 3 quarters · filed 2016-07-29 | $3.47M 10-K · filed 2016-07-29 |
| 2015-01-31 | -$393.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | -$2.87M derived: sum of 2 quarters · filed 2016-03-16 | -$5.71M 10-Q · filed 2016-03-16 | -$5.63M derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-10-31 | -$2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | -$5.32M 10-Q · filed 2015-12-15 | -$5.24M derived: sum of 3 quarters · filed 2015-12-15 | -$7.00M derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | -$2.84M 10-Q · filed 2015-09-11 | -$2.76M derived: sum of 2 quarters · filed 2015-09-11 | -$4.52M derived: sum of 3 quarters · filed 2015-09-11 | -$4.31M derived: sum of 4 quarters · filed 2015-09-11 |
| 2014-04-30 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | -$1.68M derived: sum of 2 quarters · filed 2015-07-29 | -$1.47M derived: sum of 3 quarters · filed 2015-07-29 | -$3.67M 10-K · filed 2015-07-29 |
| 2014-01-31 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -$1.55M derived: sum of 2 quarters · filed 2015-03-17 | -$3.75M 10-Q · filed 2015-03-17 | -$5.00M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-10-31 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -$1.99M 10-Q · filed 2014-12-15 | -$3.23M derived: sum of 3 quarters · filed 2014-12-15 | $5.37M derived: sum of 4 quarters · filed 2014-12-15 |
| 2013-07-31 | -$2.20M 10-Q · filed 2014-09-12 | -$3.44M derived: sum of 2 quarters · filed 2014-09-12 | $5.17M derived: sum of 3 quarters · filed 2014-09-12 | $4.41M derived: sum of 4 quarters · filed 2014-09-12 |
| 2013-04-30 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | $7.36M derived: sum of 2 quarters · filed 2014-07-28 | $6.61M derived: sum of 3 quarters · filed 2014-07-28 | $4.81M 10-K · filed 2014-07-28 |
| 2013-01-31 | $8.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | $7.85M derived: sum of 2 quarters · filed 2014-03-14 | $6.05M 10-Q · filed 2014-03-14 | $4.33M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-10-31 | -$755.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-13 | -$2.56M 10-Q · filed 2013-12-13 | -$4.28M derived: sum of 3 quarters · filed 2013-12-13 | -$4.92M derived: sum of 4 quarters · filed 2013-12-13 |
| 2012-07-31 | -$1.80M 10-Q · filed 2013-09-13 | -$3.53M derived: sum of 2 quarters · filed 2013-09-13 | -$4.17M derived: sum of 3 quarters · filed 2013-09-13 | -$5.88M derived: sum of 4 quarters · filed 2013-09-13 |
| 2012-04-30 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | -$2.37M derived: sum of 2 quarters · filed 2013-07-26 | -$4.08M derived: sum of 3 quarters · filed 2013-07-26 | -$5.70M 10-K · filed 2013-07-26 |
| 2012-01-31 | -$637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13 | -$2.36M derived: sum of 2 quarters · filed 2013-03-13 | -$3.98M 10-Q · filed 2013-03-13 | $3.54M derived: sum of 4 quarters · filed 2013-03-13 |
| 2011-10-31 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13 | -$3.34M 10-Q · filed 2012-12-13 | $4.18M derived: sum of 3 quarters · filed 2012-12-13 | $5.86M derived: sum of 4 quarters · filed 2012-12-13 |
| 2011-07-31 | -$1.62M 10-Q · filed 2012-09-12 | $5.90M derived: sum of 2 quarters · filed 2012-09-12 | $7.58M derived: sum of 3 quarters · filed 2012-09-12 | $6.75M derived: sum of 4 quarters · filed 2012-09-12 |
| 2011-04-30 | $7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $9.19M derived: sum of 2 quarters · filed 2012-07-18 | $8.37M derived: sum of 3 quarters · filed 2012-07-18 | $7.88M 10-K · filed 2012-07-18 |
| 2011-01-31 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14 | $853.00K derived: sum of 2 quarters · filed 2012-03-14 | $369.00K 10-Q · filed 2012-03-14 | |
| 2010-10-31 | -$825.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-14 | -$1.31M 10-Q · filed 2011-12-14 | ||
| 2010-07-31 | -$484.00K 10-Q · filed 2011-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |